Editorial
Copyright ©The Author(s) 2015.
World J Gastroenterol. Aug 14, 2015; 21(30): 8994-9001
Published online Aug 14, 2015. doi: 10.3748/wjg.v21.i30.8994
Figure 1
Figure 1 Small interfering RNAs/micro-interfering RNAs delivery. Ideally, the optimal delivery system should be able to discriminate between healthy hepatocytes (brown cells) and hepatocellular carcinoma cells (red cell). In addition, it should be able to protect small interfering RNAs (siRNAs)/micro-interfering RNAs (miRNAs) and favor their cellular uptake. NPs: Nanoparticles loaded with the therapeutic siRNAs/miRNAs.